357 related articles for article (PubMed ID: 19272292)
1. [The pupillary response test as a method to differentiate various types of dementia].
Grünberger J; Prause W; Frottier P; Stöhr H; Saletu B; Haushofer M; Rainer M
Neuropsychiatr; 2009; 23(1):52-7. PubMed ID: 19272292
[TBL] [Abstract][Full Text] [Related]
2. The tropicamide test in patients with dementia of Alzheimer type and frontotemporal dementia.
Robles A; Touriño R; Gude F; Noya M
Funct Neurol; 1999; 14(4):203-7. PubMed ID: 10713893
[TBL] [Abstract][Full Text] [Related]
3. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias.
Meyer JS; Huang J; Chowdhury MH
J Neurol Sci; 2007 Jun; 257(1-2):97-104. PubMed ID: 17316690
[TBL] [Abstract][Full Text] [Related]
4. Pupillary response to tropicamide in Japanese patients with alcoholic dementia, Alzheimer's disease, and vascular dementia.
Higuchi S; Matsushita S; Hasegawa Y; Muramatsu T; Arai H
Exp Neurol; 1997 Mar; 144(1):199-201. PubMed ID: 9126171
[TBL] [Abstract][Full Text] [Related]
5. Phenylephrine and pilocarpine eye drop test for dementia with Lewy bodies and Alzheimer's disease.
Hanyu H; Hirao K; Shimizu S; Kanetaka H; Sakurai H; Iwamoto T
Neurosci Lett; 2007 Mar; 414(2):174-7. PubMed ID: 17197083
[TBL] [Abstract][Full Text] [Related]
6. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
Kálmán J; Kanka A; Maglóczky E; Szóke A; Járdánházy T; Janka Z
Biol Psychiatry; 1997 Apr; 41(8):909-11. PubMed ID: 9099419
[No Abstract] [Full Text] [Related]
7. Receptor test (pupillary dilatation after application of 0.01% tropicamide solution) and determination of central nervous activation (Fourier analysis of pupillary oscillations) in patients with Alzheimer's disease.
Grünberger J; Linzmayer L; Walter H; Rainer M; Masching A; Pezawas L; Saletu-Zyhlarz G; Stöhr H; Grünberger M
Neuropsychobiology; 1999; 40(1):40-6. PubMed ID: 10420100
[TBL] [Abstract][Full Text] [Related]
8. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
[TBL] [Abstract][Full Text] [Related]
9. Probing peripheral and central cholinergic system responses.
Naranjo CA; Fourie J; Herrmann N; Lanctôt KL; Birt C; Yau KK
J Psychiatry Neurosci; 2000 Sep; 25(4):325-36. PubMed ID: 11022397
[TBL] [Abstract][Full Text] [Related]
10. Atypical dementia: when it is not Alzheimer's disease.
Bhidayasiri R
J Med Assoc Thai; 2007 Oct; 90(10):2222-32. PubMed ID: 18041446
[TBL] [Abstract][Full Text] [Related]
11. ApoE allelic variability influences pupil response to cholinergic challenge and cognitive impairment.
Scinto LF
Genes Brain Behav; 2007 Apr; 6(3):209-15. PubMed ID: 16764677
[TBL] [Abstract][Full Text] [Related]
12. Dementia: the bare essentials.
Kester MI; Scheltens P
Pract Neurol; 2009 Aug; 9(4):241-51. PubMed ID: 19608778
[No Abstract] [Full Text] [Related]
13. [The Alzheimer test].
Wilhelm H; Wilhelm B; Zrenner E
Klin Monbl Augenheilkd; 1995 Jul; 207(1):1-2. PubMed ID: 7564130
[No Abstract] [Full Text] [Related]
14. [Experience with pupil tropicamide test in Alzheimer's disease].
Robles A; Touriño R; Sesar A; Suárez P; Noya M
Rev Neurol; 1996 Jan; 24(125):65-8. PubMed ID: 8852002
[TBL] [Abstract][Full Text] [Related]
15. Tropicamide effects on pupil size and pupillary light reflexes in Alzheimer's and Parkinson's disease.
Granholm E; Morris S; Galasko D; Shults C; Rogers E; Vukov B
Int J Psychophysiol; 2003 Feb; 47(2):95-115. PubMed ID: 12568941
[TBL] [Abstract][Full Text] [Related]
16. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia?
Tiraboschi P; Salmon DP; Hansen LA; Hofstetter RC; Thal LJ; Corey-Bloom J
Brain; 2006 Mar; 129(Pt 3):729-35. PubMed ID: 16401618
[TBL] [Abstract][Full Text] [Related]
17. Neurocognitive differential diagnosis of dementing diseases: Alzheimer's Dementia, Vascular Dementia, Frontotemporal Dementia, and Major Depressive Disorder.
Braaten AJ; Parsons TD; McCue R; Sellers A; Burns WJ
Int J Neurosci; 2006 Nov; 116(11):1271-93. PubMed ID: 17000529
[TBL] [Abstract][Full Text] [Related]
18. Differences and similarities in the neuropsychological profile of dementia with Lewy bodies and Alzheimer's disease in the early stage.
Guidi M; Paciaroni L; Paolini S; De Padova S; Scarpino O
J Neurol Sci; 2006 Oct; 248(1-2):120-3. PubMed ID: 16784757
[TBL] [Abstract][Full Text] [Related]
19. Pupillary cholinergic hypersensitivity predicts cognitive decline in community dwelling elders.
Scinto LF
Neurobiol Aging; 2008 Feb; 29(2):222-30. PubMed ID: 17118493
[TBL] [Abstract][Full Text] [Related]
20. [Interest of CSF beta-amyloid1-42 and t-tau protein level determinations for the diagnosis of Alzheimer's disease].
Smach MA; Charfeddine B; Lammouchi T; Dridi H; Ben Othman L; Bennamou S; Limem K
Ann Biol Clin (Paris); 2008; 66(5):531-5. PubMed ID: 18957342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
